Clinical Trial Update: Drug Use Investigation Of Varenicline (Regulatory Post Marketing Commitment Plan)

View source ↗

Summary

Pfizer completed a post-marketing drug-use investigation for varenicline (Chantix/Champix) under regulatory commitments; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation

Drugs mentioned

• CHANTIX (varenicline tartrate)
• Varenicline (varenicline)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation | Status: COMPLETED | Results posted: 2014-01-24